OPTIMIZATION OF THERAPY FOR ACS PATIENTS WITH PHARMACOTHERAPY

Sunday, March 9, 2025

7:00 PM – 8:45 PM ET

Moderator(s)

Marc Cohen, MD

Chair of Medicine
Newark Beth Israel Med Ctr
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Neal S. Kleiman, MD, FACC, MSCAI

Medical Director, Cardiac Catheterization Laboratories
Houston Methodist DeBakey Heart and Vascular Center
Houston, Texas, United States

Disclosure information not submitted.

Disclosure(s):

Marc Cohen, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)